Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
Vir Biotechnology Inc. VIR announced a major collaboration with Gilead Sciences Inc. GILD to create three novel T-cell ...
Siren Biotechnology, a clinical-stage biotechnology company pioneering Universal AAV Immuno-Gene Therapy for cancer, today ...
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the biotechnology industry, ...
Sana Biotechnology trades at a steep discount despite promising T1D assets UP421 and SC451. Check out why SANA stock is a buy ...
Herbalife International India Pvt. Ltd. and the Indian Institute of Technology Madras (IIT Madras) launched the Herbalife–IIT Madras Phyto Innovation Accelerator Programme, an industry-academia ...
Vir Biotechnology ( ($VIR) ) has provided an update. On October 9, 2026, Vir Biotechnology entered a collaboration and license agreement with Gilead Sciences to ...
Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...
Vir Biotechnology, entered a collaboration and license agreement with Gilead to discover and engineer three novel PRO-XTEN dual-masked T-cell engager development candidates target ...
Vir Biotechnology has appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026 ...
Zacks Investment Research on MSN
PDS Biotechnology (PDSB) upgraded to buy: What does it mean for the stock?
PDS Biotechnology (PDSB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
The Defense Innovation Networking Group (D!NG) today announced that the submission window is officially open for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results